Please assess the completion status of the following clinical trial:

Trial Title: Compare the Efficacy of Rosuvastatin to Atorvastatin in High Risk Patients With Hypercholesterolemia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Treated for or diagnosed hypercholesterolemia or have had a high risk with hypercholesterolemia~* LDL-C between 3.36mmol/L and 6.5 mmol/L if not treated with statin or between 2.6mmol/L and 4.14 mmol/L~* Fasting triglyceride less than 4.52mmol/L~Exclusion Criteria:~* History of statin induced myopathy~* Unstable or uncontrolled cardiovascular diseases~* Familial dysbetalipoproteinemia

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): Rosuvastatin 5mg qd
- 2 (Type: EXPERIMENTAL): Rosuvastatin 10mg qd
- 3 (Type: ACTIVE_COMPARATOR): Atorvastatin 10mg qd

Based on this trial design, predict the completion outcome and termination type (if applicable).